British Journal of Clinical Pharmacology

Pulse wave analysis
pp. 507-522(16)
Authors: O'Rourke, Michael F.; Pauca, Alfredo; Jiang, Xiong-Jing

Stopping rules for phase II studies
pp. 523-529(7)
Authors: Stallard, Nigel; Whitehead, John; Todd, Susan; Whitehead, Anne

6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations
pp. 531-539(9)
Authors: Lancaster, D. L.; Patel, N.; Lennard, L.; Lilleyman, J. S.

Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria
pp. 541-546(6)
Authors: Binh, Tran Quang; Ilett, Kenneth F.; Batty, Kevin T.; Davis, Timothy M. E.; Hung, Nguyen Canh; Powell, Shane M.; Thu, Le Thi Anh; Van Thien, Huynh; Phuöng, Hoang Lan; Phuong, Vu Duong Bich

Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol
pp. 547-555(9)
Authors: Gross, A. S.; McLachlan, A. J.; Minns, I.; Beal, J. B.; Tett, S. E.

Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome—a population pharmacokinetic study
pp. 557-565(9)
Authors: Mouly, Stéphane; Aymard, Guy; Tillement, Jean-Paul; Caulin, Charles; Bergmann, Jean-Francois; Urien, Saik

Population pharmacokinetics of carbamazepine in Singapore epileptic patients
pp. 567-576(10)
Authors: Chan, Eli; Lee, How Sung; Hue, Swee Shan

Platelet CD62 expression and PDGF_AB secretion in patients undergoing PTCA and treatment with abciximab
pp. 577-582(6)
Authors: Graff, J.; Andries, D.; Elsner, M.; Westrup, D.; Bassus, S.; Franz, N.; Klinkhardt, U.; Harder, S.

Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man
pp. 583-589(7)
Authors: Abdelmawla, A. H.; Langley, R. W.; Szabadi, E.; Bradshaw, C. M.

Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
pp. 591-600(10)
Authors: Khaliq, Yasmin; Gallicano, Keith; Tisdale, Christine; Carignan, Germain; Cooper, Curtis; McCarthy, Anne

Public health impact of adverse bone effects of oral corticosteroids
pp. 601-607(7)
Authors: van Staa, T. P.; Abenhaim, L.; Cooper, C.; Zhang, B.; Leufkens, H. G. M.

A 6-month large-scale study into the safety of tamsulosin
pp. 609-614(6)
Authors: Michel, M. C.; Bressel, H.-U.; Goepel, M.; Rübben, H.

Drug therapy in the elderly: what doctors believe and patients actually do
pp. 615-622(8)
Authors: Barat, I.; Andreasen, F.; Damsgaard, E. M. S.

Recording previous adverse drug reactions—a gap in the system
pp. 623-626(4)
Authors: Shenfield, Gillian M.; Robb, Tanya; Duguid, Margaret

Is cytochrome P450 2C9 genotype associated with NSAID gastric ulceration?
pp. 627-630(4)
Authors: Martin, Jennifer H.; Begg, Evan J.; Kennedy, Martin A.; Roberts, Rebecca; Barclay, Murray L.

The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals
pp. 631-635(5)
Authors: Koks, C. H. W.; Crommentuyn, K. M. L.; Hoetelmans, R. M. W.; Burger, D. M.; Koopmans, P. P.; Mathôt, R. A. A.; Mulder, J. W.; Meenhorst, P. L.; Beijnen, J. H.